SARmont is a trusted provider of medicinal chemistry design and lead optimization services. Our scientific team is led by Dr. John Talley, the inventor of Celebrex and seven other drugs that successfully reached the market. Our team works collaboratively with clients to identify and optimize proprietary investigational new drug (IND) candidates. We use a combination of rational drug design, insightful activity trend analysis, informed interpretation of medical need, and careful synthetic planning. To assure cost efficient compound synthesis we utilize a respected high quality strategic CRO partner in Asia. All IP is retained by our clients – we streamline and accelerate your drug design process, through effective project management of the design, synthesis and lead optimization process.